Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
Regen Biopharma, Inc. Common (RGBP)
NASDAQ:AMEX Investor Relations:
regenbiopharmainc.com/investor-relations.html
Company Research
Source: PR Newswire
Regen BioPharma, Inc. invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.SAN DIEGO, April 2, 2024 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on April 4, 2024 (https://emerginggrowth.com/conference/).This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Dr. David Koos, in real time. Please ask your questions during the event and Dr. Koos and his team will do their best to address as many of them as possible."We plan to use this time to update our shareholders on current plans and opportunities to advance our most advanced asset, HemaXellerate, i
Show less
Read more
Impact Snapshot
Event Time:
RGBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGBP alerts
High impacting Regen Biopharma, Inc. Common news events
Weekly update
A roundup of the hottest topics
RGBP
News
- Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024 [Yahoo! Finance]Yahoo! Finance
- Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024 [Yahoo! Finance]Yahoo! Finance
- Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024PR Newswire
- Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024 [Yahoo! Finance]Yahoo! Finance
- Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024PR Newswire
RGBP
Sec Filings
- 4/29/24 - Form 424B3
- 4/29/24 - Form 8-K
- 4/24/24 - Form 424B3
- RGBP's page on the SEC website